Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Short Interest Update

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) was the recipient of a large decrease in short interest in January. As of January 15th, there was short interest totaling 3,024 shares, a decrease of 64.3% from the December 31st total of 8,463 shares. Based on an average daily volume of 118,888 shares, the short-interest ratio is presently 0.0 days. Based on an average daily volume of 118,888 shares, the short-interest ratio is presently 0.0 days.

Alpha Tau Medical Stock Performance

Shares of NASDAQ DRTSW opened at $0.96 on Wednesday. The stock’s fifty day moving average is $0.48 and its 200 day moving average is $0.36. Alpha Tau Medical has a 52 week low of $0.13 and a 52 week high of $1.18.

About Alpha Tau Medical

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.